{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:40:28Z","timestamp":1761237628920},"reference-count":18,"publisher":"Wiley","issue":"7-8","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4680,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[1996,7]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> Clinical and laboratory data from 22 children with tinea corporis and tinea capitis caused by <jats:italic>Microsporum canis<\/jats:italic> (10 tinea corporis, 12 tinea capitis), confirmed by microscopic examination and culture and partly pretreated with griseofulvin or terbinafine, are summarized. The children were treated consecutively with itraconazole in our clinic during 1994\/95. The age of the children ranged between 4 and 13 years, with girls being affected much more frequently than boys. Oral, individually adapted, high\u2010dose treatment of 5 mg itraconazole per kg body weight proved to be successful. In all 22 children, although pretreatment with griseofulvin or terbinafine was partly unsuccessful, fungal infections could be cured clinically and also were culture negative at control examinations. In 10 children with tinea corporis treatment was performed only for 4\u201314 (middle 11) days. In the children with tinea capitis itraconazoie treatment was continued for 3\u201311 weeks. Among the six children without pretreatment, itraconazole solution was administered for 4\u201311 weeks (average 7.5 weeks). Of the patients in whom pretreatment was unsuccessful, four with griseofulvin and two with terbinafine, the duration of the subsequent oral treatment with itraconazole solution was 3\u20135 weeks (average 3.6 weeks). The drug seemed to be well tolerated\u2014no significant side\u2010effects occurred, with the exception of possible minor gastrointestinal disturbances in two patients. Laboratory values remained within normal limits.<\/jats:p><jats:p><jats:bold>Zusammenfassung. <\/jats:bold> Ergebnisse von 22 Kindern mit <jats:italic>Microsporum canis<\/jats:italic>\u2010Infektionen (10 Tinea corporis\u2010 und 12 Tinea capitis\u2010Patienten), welche konsekutiv und unausgew\u00e4hlt im Jahre 1994\/1995 an unserer Klinik mit Itraconazol\u2010Suspension the\u2010rapiert wurden, werden dargelegt. Die Kinder waren zum Teil ausw\u00e4rts erfolglos mit Griseofulvin oder Terbinafin vorbehandelt worden. Der Altersgipfel der vorwiegend M\u00e4dchen betreffenden Erkrankung lag zwischen dem 5.\u20108. Lebensjahr. Eine systemische, individuelle, dem K\u00f6rpergewicht mit 5 mg Itraconazol\/kg angepa\u00dfte hoch dosierte Therapie hat sich bew\u00e4hrt. Bei allen 22 Kindern\u2014einschlie\u00dflich der mit Griseofulvin bzw. Terbinafin vorbehandelten\u2014konnte die Mykose klinisch wie auch mykologisch geheilt werden. Bei den 10 Kindern mit Tinea corporis war eine Therapiedauer von 4\u201314 Tagen (Mittelwert 11 Tage) ausreichend. Bei den 12 Kindern mit Tinea capitis war die Therapiedauer mit Itraconazol abh\u00e4ngig von einer m\u00f6glichen Vorbehandlung und lag zwischen 3\u201311 Wochen: ohne Vorbehandlung 4\u201311 Wochen (Mittelwert 7.5 Wochen), bei erfolgloser l\u00e4ngerer Vorbehandlung 3\u20135 Wochen (Mittelwert 3.6 Wochen). Bedeutende Nebenwirkungen wurden nicht beobachtet. Bei 2 Kindern traten leichte gastrointestinale St\u00f6rungen auf, die vielleicht auf die erfolgte Therapie zur\u00fcckzuf\u00fchren waren. Blutbild und Leberfunktion waren bei Laborkontrollen unauff\u00e4llig.<\/jats:p>","DOI":"10.1111\/j.1439-0507.1996.tb00136.x","type":"journal-article","created":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T16:40:45Z","timestamp":1240591245000},"page":"265-269","source":"Crossref","is-referenced-by-count":16,"title":["<i>Microsporum canis<\/i> infections in children: results of a new oral antifungal therapy"],"prefix":"10.1111","volume":"39","author":[{"given":"Gabriele","family":"Ginter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/myc.1990.33.2.86"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02210.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1991.tb03853.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1989.tb02193.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199243050-00004"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1986.tb03775.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.125.1.113"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70251-C"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1994.tb01525.x"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb02608.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70137-7"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70254-F"},{"key":"e_1_2_1_14_2","unstructured":"Nolting S. Gupta A. K. Prost deY.et al.(1995)Itraconazole for the treatment of dermatomycoses in children.International Symposium on Onychomycosis Florence 1995."},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70253-E"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0934-8840(11)80253-7"},{"key":"e_1_2_1_17_2","first-page":"115","article-title":"Dermatophytosen durch Microsporum canis und Microsporum audouinii in der Umgebung Greifswalds","volume":"176","author":"Schr\u00f6der G.","year":"1990","journal-title":"Dermatol. Monatsschr."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-00524-8"},{"key":"e_1_2_1_19_2","first-page":"451","article-title":"Successful treatment of griseofulvin\u2010resistant tinea capitis in infants","volume":"27","author":"Lucas A.","year":"1994","journal-title":"Mycoses"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.1996.tb00136.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.1996.tb00136.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:02:14Z","timestamp":1693504934000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.1996.tb00136.x"}},"subtitle":["Ergebnisse der systemischen Therapie von <i>Microsporum canis<\/i>\u2010Infektionen bei Kindern mit einem neuen Antimykotikum"],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":18,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["10.1111\/j.1439-0507.1996.tb00136.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.1996.tb00136.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,7]]}}}